UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
10-K
☒
ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For
the fiscal year ended December 31 , 2021
☐
TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934
For
the transition period from
to
Commission
File Number: 000-56252
HONG
YUAN HOLDING GROUP
(Exact
name of registrant as specified in its charter)
Nevada
91-2154289
(State
or Other Jurisdiction
(I.R.S.
Employer
of
Incorporation or organization)
Identification
No.)
Room
2707, Global Mansion , Zhengbian Road , Jinhui District ,
Zhengzhou
City , Henan Province, China 450000
(Address
of principal executive offices)
+861
8999250338
(Registrant’s
telephone number, including area code)
Securities
Registered Pursuant to Section 12(g) of The Act: Common Stock, $0.001 Par Value
Indicate
by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐ No
☒
Indicate
by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No
☒
Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate
by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive
Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☐ No
☒
Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company,
or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller
reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large
accelerated filer ☐
Accelerated
filer ☐
Non-accelerated
filer ☐
Smaller
reporting company ☒
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐
Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☒ No ☐
As of June 30, 2021, the aggregate market value
of our common stock held by non-affiliates was $ 6,844,370 , based on 22,814,566 shares of outstanding common stock held by non-affiliates,
and a price of $0.3 per share.
Indicate
the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. The number
of shares outstanding of the registrant’s common stock as of March 9, 2022 was 74,640,766 .
HONG
YUAN HOLDING GROUP
Page
No.
PART I
Item
1
Business
4
Item
1A
Risk Factors
8
Item
1B
Unresolved Staff Comments
8
Item
2
Properties
8
Item
3
Legal Proceedings
8
Item
4
Mine Safety Disclosures
8
Part II
Item
5
Market For Registrant’s Common Equity, Related Stockholder Matters And Issuer Purchases Of Equity Securities
9
Item
6
Selected Financial Data
10
Item
7
Management’s Discussion And Analysis Of Financial Condition And Results Of Operations
10
Item
7A
Quantitative And Qualitative Disclosures About Market Risk
13
Item
8
Financial Statements And Supplementary Data
13
Item
9
Changes In And Disagreements With Accountants On Accounting And Financial Disclosure
13
Item
9A
Controls And Procedures
13
Item
9B
Other Information
14
Part III
Item
10
Directors And Executive Officers And Corporate Governance
14
Item
11
Executive Compensation
16
Item
12
Security Ownership Of Certain Beneficial Owners And Management And Related Stockholder Matters
16
Item
13
Certain Relationships And Related Transactions, And Director Independence
17
Item
14
Principal Accountant Fees And Services
17
Part IV
Item
15
Exhibits And Financial Statement Schedules
18
Signatures
20
2
In
this annual report the words “we,” “us,” “our,” and the “Company” refer to Hong Yuan
Holding Group.
FORWARD
LOOKING STATEMENTS
When
used in this report, the words “may,” “will,” “expect,” “anticipate,” “continue,”
“estimate,” “project,” “intend,” and similar expressions are intended to identify forward-looking
statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 regarding
events, conditions, and financial trends that may affect the Company’s future plans of operations, business strategy, operating
results, and financial position. Persons reviewing this report are cautioned that any forward-looking statements are not guarantees of
future performance and are subject to risks and uncertainties and that actual results may differ materially from those included within
the forward-looking statements as a result of various factors.
Statements
made in this Form 10-K that are not historical or current facts are “forward-looking statements” made pursuant to the safe
harbor provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. We wish to caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date
made. Any forward-looking statements represent our best judgment as to what may occur in the future. These forward-looking statements
include our plans and objectives for our future growth, including plans and objectives related to the consummation of acquisitions and
future private and public issuances of our equity and debt securities. The forward-looking statements included herein are based on current
expectations that involve numerous risks and uncertainties. Assumptions relating to the foregoing involve judgments with respect to,
among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible
to predict accurately and many of which are beyond our control. Although we believe that the assumptions underlying the forward-looking
statements are reasonable, any of the assumptions could be inaccurate and, therefore, there can be no assurance that the forward-looking
statements included in this Form 10-K will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking
statements included herein, you should not regard the inclusion of such information as our representation or the representation of any
other person that we will achieve our objectives and plans. We disclaim any obligation subsequently to revise any forward-looking statements
to reflect events or circumstances after the date of such statement or to reflect the occurrence of anticipated or unanticipated events.
3
PART
I
Item 1
Business.
Our
Company
Hong
Yuan Holding Group, formerly Cereplast, Inc., a Nevada corporation (“Hong Yuan”, the “Company, “we”, “us”
or “our”) is a public shell company seeking to create value for its shareholders by merging with another entity with experienced
management and opportunities for growth in return for shares of our common stock.
No
potential merger candidate has been identified at this time.
We
do not propose to restrict our search for a business opportunity to any particular industry or geographical area and may, therefore,
engage in essentially any business in any industry. We have unrestricted discretion in seeking and participating in a business opportunity,
subject to the availability of such opportunities, economic conditions, and other factors.
The
selection of a business opportunity in which to participate is complex and risky. Additionally, we have only limited resources and may
find it difficult to locate good opportunities. There can be no assurance that we will be able to identify and acquire any business opportunity
which will ultimately prove to be beneficial to us and our shareholders. We will select any potential business opportunity based on our
management’s best business judgment.
Our
activities are subject to several significant risks, which arise primarily as a result of the fact that we have no specific business,
and may acquire or participate in a business opportunity based on the decision of management, which potentially could act without the
consent, vote, or approval of our shareholders. The risks faced by us are further increased as a result of its lack of resources and
our inability to provide a prospective business opportunity with significant capital.
Our
History
Organization
and Corporate History
The
Company was incorporated in the state of Nevada on September 14, 2001 under the name Biocorp North America, Inc. On July 19, 2004 the
Company changed its name to Nat-UR, Inc. and on March 18, 2005 it changed its name again to Cereplast, Inc.
We
had developed and were commercializing proprietary bio-based resins through two complementary product families: Cereplast Compostables
resins which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins
(including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics
with materials from renewable resources. Our resins could be converted into finished products using conventional manufacturing equipment
without significant additional capital investment by downstream converters. In the summer of 2014, the Company ceased all operations
and since that time has been inactive
On
May 7, 2014, we voluntarily converted our Chapter 11 filing to a Chapter 7 filing in the U.S. Bankruptcy Court for the Southern District
of Indiana. We ceased all business activities in August 2014. May 10, 2019, the Trustees’ Final Account, the Certification of Full
Administration and Application for Discharge was filed and accepted by the Court. All debts and liabilities were paid or discharged.
On May 11, 2019, the Bankruptcy Case was closed.
On
March 22, 2019, the eight judicial District Court of Nevada appointed Custodian Ventures, LLC as custodian for Cereplast, Inc., proper
notice having been given to the officers and directors of Cereplast, Inc. There was no opposition.
On
June 04, 2019, the Company filed a certificate of revival with the state of Nevada, appointing David Lazar as, President, Secretary,
Treasurer and Director.
4
A
change of control of the Company was completed on November 3, 2020, Pursuant to a Stock Purchase Agreement dated October 22, 2020 control
was obtained by the sale of 50,000,000 common shares and 5,000,000 Series A-1 Preferred Shares from Custodian Ventures, LLC to Xudong
Li. After November 3, 2020, the Company’s operations are determined and structured by the new major shareholder.
General
Business Plan
Our
business plan to seek a merger has many uncertainties which pose risks to investors.
We
intend to seek, investigate and, if such investigation warrants, acquire an interest in business opportunities presented to us by persons
or firms which desire to seek the advantages of an issuer who has complied with the Securities Act of 1934 (the “1934 Act”).
We will not restrict our search to any specific business, industry or geographical location, and we may participate in business ventures
of virtually any nature. This discussion of our proposed business is purposefully general and is not meant to be restrictive of our unlimited
discretion to search for and enter into potential business opportunities. We anticipate that we may be able to participate in only one
potential business venture because of our lack of financial resources. We may seek a business opportunity with entities which have recently
commenced operations, or that desire to utilize the public marketplace in order to raise additional capital in order to expand into new
products or markets, to develop a new product or service, or for other corporate purposes. All of these activities have risk to investors
including dilution and management.
We
expect that the selection of a business opportunity will be complex. Due to general economic conditions, rapid technological advances
being made in some industries and shortages of available capital, we believe that there are numerous firms seeking the benefits of an
issuer who has complied with the 1934 Act. Such benefits may include facilitating or improving the terms on which additional equity financing
may be sought, providing liquidity for incentive stock options or similar benefits to key employees, providing liquidity (subject to
restrictions of applicable statutes) for all stockholders and other factors. Potentially, available business opportunities may occur
in many different industries and at various stages of development, all of which will make the task of comparative investigation and analysis
of such business opportunities extremely difficult and complex. We have, and will continue to have, essentially no assets to provide
the owners of business opportunities. However, we will be able to offer owners of acquisition candidates the opportunity to acquire a
controlling ownership interest in an issuer who has complied with the 1934 Act without incurring the cost and time required to conduct
an initial public offering.
The
analysis of new business opportunities will be undertaken by, or under the supervision of, our Board of Directors. We intend to concentrate
on identifying preliminary prospective business opportunities which may be brought to our attention through present associations of our
director, professional advisors or by our stockholders. In analyzing prospective business opportunities, we will consider such matters
as (i) available technical, financial and managerial resources; (ii) working capital and other financial requirements; (iii) history
of operations, if any, and prospects for the future; (iv) nature of present and expected competition; (v) quality, experience and depth
of management services; (vi) potential for further research, development or exploration; (vii) specific risk factors not now foreseeable
but that may be anticipated to impact the proposed activities of the company; (viii) potential for growth or expansion; (ix) potential
for profit; (x) public recognition and acceptance of products, services or trades; (xi) name identification; and (xii) other factors
that we consider relevant. As part of our investigation of the business opportunity, we expect to meet personally with management and
key personnel. To the extent possible, we intend to utilize written reports and personal investigation to evaluate the above factors.
We
will not acquire or merge with any company for which audited financial statements cannot be obtained within a reasonable period of time
after closing of the proposed transaction.
Acquisition
Interest
In
implementing a structure for a particular business acquisition, we may become a party to a merger, consolidation, reorganization, joint
venture, or licensing agreement with another company or entity. We may also acquire stock or assets of an existing business. Upon consummation
of a transaction, it is probable that our present management and stockholders will no longer be in control of us. In addition, our directors
may, as part of the terms of the acquisition transaction, resign and be replaced by new directors without a vote of our stockholders,
or sell his stock in us. Any such sale will only be made in compliance with the securities laws of the United States and any applicable
state.
5
It
is anticipated that any securities issued in any such reorganization would be issued in reliance upon exemption from registration under
application federal and state securities laws. In some circumstances, as a negotiated element of the transaction, we may agree to register
all or a part of such securities immediately after the transaction is consummated or at specified times thereafter. If such registration
occurs, it will be undertaken by the surviving entity after it has successfully consummated a merger or acquisition and is no longer
considered an inactive company.
The
issuance of substantial additional securities and their potential sale into any trading market which may develop in our securities may
have a depressive effect on the value of our securities in the future. There is no assurance that such a trading market will develop.
While
the actual terms of a transaction cannot be predicted, it is expected that the parties to any business transaction will find it desirable
to avoid the creation of a taxable event and thereby structure the business transaction in a so-called “tax-free” reorganization
under Sections 368(a)(1) or 351 of the Internal Revenue Code (the “Code”). In order to obtain tax-free treatment under the
Code, it may be necessary for the owner of the acquired business to own 80% or more of the voting stock of the surviving entity. In such
event, our stockholders would retain less than 20% of the issued and outstanding shares of the surviving entity. This would result in
significant dilution in the equity of our stockholders.
As
part of our investigation, we expect to meet personally with management and key personnel, visit and inspect material facilities, obtain
independent analysis of verification of certain information provided, check references of management and key personnel, and take other
reasonable investigative measures, to the extent of our limited financial resources and management expertise. The manner in which we
participate in an opportunity will depend on the nature of the opportunity, the respective needs and desires of both parties, and the
management of the opportunity.
With
respect to any merger or acquisition, and depending upon, among other things, the target company’s assets and liabilities, our
stockholders will in all likelihood hold a substantially lesser percentage ownership interest in us following any merger or acquisition.
The percentage ownership may be subject to significant reduction in the event we acquire a target company with assets and expectations
of growth. Any merger or acquisition can be expected to have a significant dilutive effect on the percentage of shares held by our stockholders.
We
will participate in a business opportunity only after the negotiation and execution of appropriate written business agreements. Although
the terms of such agreements cannot be predicted, generally we anticipate that such agreements will (i) require specific representations
and warranties by all of the parties; (ii) specify certain events of default; (iii) detail the terms of closing and the conditions which
must be satisfied by each of the parties prior to and after such closing; (iv) outline the manner of bearing costs, including costs associated
with the Company’s attorneys and accountants; (v) set forth remedies on defaults; and (vi) include miscellaneous other terms.
As
stated above, we will not acquire or merge with any entity which cannot provide independent audited financial statements within a reasonable
period of time after closing of the proposed transaction. If such audited financial statements are not available at closing, or within
time parameters necessary to insure our compliance within the requirements of the 1934 Act, or if the audited financial statements provided
do not conform to the representations made by that business to be acquired, the definitive closing documents will provide that the proposed
transaction will be voidable, at the discretion of our present management. If such transaction is voided, the definitive closing documents
will also contain a provision providing for reimbursement for our costs associated with the proposed transaction.
The
Company is a Blank Check Company
At
present, the Company is a development stage company with minimal assets and no specific business plan or purpose. The Company’s
business plan is to seek new business opportunities or to engage in a merger or acquisition with an unidentified company. As a result,
the Company is a “blank check company” and, as a result, any offerings of the Company’s securities under the Securities
Act of 1933, as amended (the “Securities Act”) must comply with Rule 419 promulgated by the Securities and Exchange Commission
(the “SEC”) under the Act. The Company’s Common Stock is a “penny stock,” as defined in Rule 3a51-1 promulgated
by the SEC under the Securities Exchange Act. The Penny Stock rules require a broker-dealer, prior to a transaction in penny stock not
otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about Penny Stocks and
the nature and level of risks in the penny stock market.
6
The
broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, the compensation of the broker-dealer
and its salesperson in the transaction, and monthly account statements showing the market value of each Penny Stock held in the customer’s
account. Also, the Penny Stock rules require that the broker-dealer, not otherwise exempt from such rules, must make a special written
determination that the Penny Stock is suitable for the purchaser and receive the purchaser’s written agreement to the transaction.
These disclosure rules have the effect of reducing the level of trading activity in the secondary market for a stock that becomes subject
to the Penny Stock rules. So long as the common stock of the Company is subject to the Penny Stock rules, it may be more difficult to
sell the Company’s common stock.
We
are a “Shell Company,” as defined in Rule 405 promulgated by the SEC under the Securities Act. A Shell Company is one that
has no or nominal operations and either: (i) no or nominal assets; or (ii) assets consisting primarily of cash or cash equivalents. As
a Shell Company, we are restricted in our use of Registrations on Form S-8 under the Securities Act; the lack of availability of the
use of Rule 144 by security holders; and the lack of liquidity in our stock.
Unavailability
of Rule 144 for Resale
Rule
144(i) “Unavailability to Securities of Issuers With No or Nominal Operations and No or Nominal Non-Cash Assets” provides
that Rule 144 is not available for the resale of securities initially issued by an issuer that is a Shell Company. We have identified
our company as a Shell Company and, therefore, the holders of our securities may not rely on Rule 144 to have the restriction removed
from their securities without registration or until the Company is no longer identified as a Shell Company and has filed all requisite
periodic reports under the Exchange Act for twelve (12) months.
As
a result of our classification as a Shell Company, our investors are not allowed to rely on the “safe harbor” provisions
of Rule 144, promulgated pursuant to the Securities Act, so as not to be considered underwriters in connection with the sale of our securities
until one year from the date that we cease to be a Shell Company. This will likely make it more difficult for us to attract additional
capital through subsequent unregistered offerings because purchasers of securities in such unregistered offerings will not be able to
resell their securities in reliance on Rule 144, a safe harbor on which holders of restricted securities usually rely to resell securities.
Rule
419 of the Securities Act
The
provisions of Rule 419 apply to registration statements filed under the Securities Act by a blank check company, such as the Company.
Rule 419 requires that a blank check company filing a registration statement deposit the securities being offered and proceeds of the
offering into an escrow or trust account pending the execution of an agreement for an acquisition or merger. While we are not currently
registering shares for an offering, we may do so in the future.
In
addition, an issuer is required to file a post-effective amendment to a registration statement upon the execution of an agreement for
an acquisition or merger. The rule provides procedures for the release of the offering funds, if any, in conjunction with the post-effective
acquisition or merger. The obligations to file post-effective amendments are in addition to the obligations to file Forms 8-K to report
for both the entry into a material definitive (non-ordinary course of business) agreement and the completion of the transaction. Rule
419 applies to both primary and re-sale or secondary offerings.
Within
five (5) days of filing a post-effective amendment setting forth the proposed terms of an acquisition, the Company must notify each investor
whose shares are in escrow, if any. Each such investor then has no fewer than 20 and no greater than 45 business days to notify the Company
in writing if they elect to remain an investor. A failure to reply indicates that the person has elected to not remain an investor. As
all investors are allotted this second opportunity to determine to remain an investor, acquisition agreements should be conditioned upon
enough funds remaining in escrow to close the transaction.
7
Competition
We
believe we are an insignificant participant among the firms which engage in the acquisition of business opportunities. There are many
established venture capital and financial concerns that have significantly greater financial and personnel resources and technical expertise
than we have. In view of our limited financial resources and limited management availability, we will continue to be at a significant
competitive disadvantage compared to our competitors.
Investment
Company Act 1940
Although
we will be subject to regulation under the Securities Act of 1933, as amended, and the 1934 Act, we believe we will not be subject to
regulation under the Investment Company Act of 1940 (the “1940 Act”) insofar as we will not be engaged in the business of
investing or trading in securities. In the event we engage in business combinations that result in us holding passive investment interests
in a number of entities, we could be subject to regulation under the 1940 Act. In such event, we would be required to register as an
investment company and incur significant registration and compliance costs. We have obtained no formal determination from the SEC as
to our status under the 1940 Act and, consequently, any violation of the 1940 Act would subject us to material adverse consequences.
We believe that, currently, we are exempt under Regulation 3a-2 of the 1940 Act.
Intellectual
Property
We
own no intellectual property.
Employees
We
presently have no full time executive, operational, or clerical staff.
Ms.
Xudong has been a director and officer of the Company since 2020 and its principal shareholder.
Factors
Effecting Future Performance
Rather
than an operating business, our goal is to obtain debt and/or equity financing to meet our ongoing operating expenses and attempt to
merge with another entity with experienced management and opportunities for growth in return for shares of our common stock to create
value for our shareholders.
Although
there is no assurance that this series of events will be successfully completed, we believe we can successfully complete an acquisition
or merger which will enable us to continue as a going concern. Any acquisition or merger will most likely be dilutive to our existing
stockholders.
Item
1A.
Risk Factors
This
item is inapplicable because we are a “smaller reporting company” as defined in Exchange Act Rule 12b-2.
Item
1B.
Unresolved Staff Comments
This
item is inapplicable because we are a “smaller reporting company” as defined in Exchange Act Rule 12b-2.
Item
2
Properties.
The
Company has no properties and at this time has no agreements to acquire any properties. The Company currently uses an office provided
by Ms. Xudong, the Company’s President and CEO, at no cost to the Company. Ms. Xudong has agreed to continue this arrangement until
the Company completes an acquisition or merger. We presently do not own any equipment, and do not intend to purchase or lease any equipment
prior to or upon completion of a business combination.
Item
3
Legal Proceedings.
Neither
we nor any of our officers, directors or holders of five percent or more of its common stock is a party to any pending legal proceedings
and to the best of our knowledge, no such proceedings by or against us or our officers, or directors or holders of five percent or more
of its common stock have been threatened or is pending against us.
Item
4
Mine Safety Disclosures.
Not
applicable
8
PART
II
Item
5
Market For Registrant’s Common Equity, Related Stockholder
Matters And Issuer Purchases Of Equity Securities.
Market
Information
Shares
of our common stock trade in the pink sheets market and quotations for the common stock are listed in the “Pink Sheets” produced
by the OTC Markets under the symbol “HGYN”.
The
following table sets forth for the respective periods indicated the prices of our common stock in this market as reported and summarized
by the National Quotation Bureau. Such prices are based on inter-dealer bid and asked prices, without markup, markdown, commissions,
or adjustments and may not represent actual transactions.
Year ended December 31, 2020
High
Low
First Quarter
$ .001
$ .0003
Second Quarter
.0015
.001
Third Quarter
.002
.0003
Fourth Quarter
.002
.0003
Year ended December 31, 2021
High
Low
First Quarter
$ 0.52
$ 0.023
Second Quarter
0.98
0.094
Third Quarter
0.45
0.181
Fourth Quarter
0.24
0.176
Holders
There
were 206 holders of record as of December 31, 2021; however, we believe the number of beneficial holders of our shares of common stock
to be approximately 290. In many instances, a registered stockholder is a broker or other entity holding shares in street name for one
or more customers who beneficially own the shares.
Dividends
We
have never paid cash dividends and have no plans to do so in the foreseeable future. Our future dividend policy will be determined by
our board of directors and will depend upon a number of factors, including our financial condition and performance, our cash needs and
expansion plans, income tax consequences, and the restrictions that applicable laws, any future preferred stock instruments, and any
future credit arrangements may then impose.
Issuer
Purchases of Equity Securities
None.
9
Securities
Authorized for Issuance under Equity Compensation Plans
The
Company does not have any equity compensation plans or any individual compensation arrangements with respect to its Common Stock or Preferred
Stock. The issuance of any of our Common Stock or Preferred Stock is within the discretion of our Board of Directors, which has the power
to issue any or all of our authorized but unissued shares without stockholder approval.
Recent
Sales of Unregistered Equity Securities
On
October 04, 2019, the Company issued 50,000,000 shares of common stock to Custodian Ventures, LLC at par for shares valued at $50,000
in exchange for settlement of a portion of a related party loan for amounts advanced to the Company in the amount of $20,100, and a note
receivable due to the Company in the amount of $29,900. The note bears an interest of 3% and matures in 180 days following written demand
by the holder. At December 31, 2020, the note receivable with a balance of $31,383 was written off because the collectability of the
note is unlikely after the change of control, the written off balance of the note consisted of the principal in the amount of $29,900
and interest receivable of $1,483.
On
May 4, 2020, the Company issued 5,000,000 shares of the Series A-1 Preferred stock valued at $5,000 to Custodian Ventures LLC as repayment
of funds loaned to the Company
All
of the securities set forth above were sold pursuant to exemptions from registration under Section 4(2) of the Securities Act of 1933,
as amended, as transactions by an issuer not involving any public offering. No general advertising or solicitation was used. And the
investors were purchasing the Shares for investment purposes only, without a view to resale. All issued securities were affixed with
appropriate legends restricting sales and transfers.
Item
6
Selected Financial Data.
This
item is inapplicable because we are a “smaller reporting company” as defined in Exchange Act Rule 12b-2.
Item
7
Management’s Discussion And Analysis Of Financial
Condition And Results Of Operations.
Forward
Looking Statement Notice
This
Current Report on Form 10-K contains forward-looking statements within the meaning of the federal securities laws. These include statements
about our expectations, beliefs, intentions or strategies for the future, which we indicate by words or phrases such as “anticipate,”
“expect,” “intend,” “plan,” “will,” “we believe,” “believes,”
“management believes” and similar language. Except for the historical information contained herein, the matters discussed
in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and elsewhere in this
report are forward-looking statements that involve risks and uncertainties. The factors listed in the section captioned “Risk Factors,”
as well as any cautionary language in this report; provide examples of risks, uncertainties and events that may cause our actual results
to differ materially from those projected. Except as may be required by law, we undertake no obligation to update any forward-looking
statement to reflect events after the date of this Form 10-K.
Overview
The
Company was incorporated in the state of Nevada on September 14, 2001 under the name Biocorp North America, Inc. On July 19, 2004 the
Company changed its name to Nat-UR, Inc. and on March 18, 2005 it changed its name again to Cereplast, Inc.
We
had developed and were commercializing proprietary bio-based resins through two complementary product families: Cereplast Compostables
resins which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins
(including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics
with materials from renewable resources. Our resins could be converted into finished products using conventional manufacturing equipment
without significant additional capital investment by downstream converters. In the summer of 2014, the Company ceased all operations
and since that time has been inactive.
10
On
March 22, 2019, the eight judicial District Court of Nevada appointed Custodian Ventures, LLC as custodian for Cereplast, Inc., proper
notice having been given to the officers and directors of Cereplast, Inc. There was no opposition.
On
June 04, 2019, the Company filed a certificate of revival with the state of Nevada, appointing David Lazar as, President, Secretary,
Treasurer and Director.
A
change of control of the Company was completed on November 3, 2020, control was obtained by the sale of 50,000,000 common shares and
$5,000,000 Series A-1 Preferred Shares from Custodian Ventures, LLC to Xudong Li. After November 3, 2020, the Company’s operations
are determined and structured by the new major shareholder.
We
have not yet generated sustained profits from our prior operations. Our independent accountants have expressed a “going concern”
opinion. As of December 31, 2021, we had an accumulated deficit of $97,318,853 and a net working capital deficit of $53,176.
While
our current burn rate is nominal, it is expected that our costs of operations will continue to exceed revenues, primarily due to the
costs associated with being a public reporting company. Based upon our current business plan, we may continue to incur losses in the
foreseeable future and there can be no assurances that we will ever establish profitable operations. These and other factors raise substantial
doubt about our ability to continue as a going concern.
Critical
Accounting Policies, Judgments and Estimates
Our
discussion and analysis of our financial condition and results of operations is based upon our consolidated financial statements, which
have been prepared in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”). The preparation of these consolidated
financial statements requires us to make estimates, judgments and assumptions that affect the reported amounts of assets, liabilities,
revenues and expenses, and the related disclosure of contingent assets and liabilities. We base our estimates on historical experience
and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making
judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ
from these estimates.
An
accounting policy is considered to be critical if it requires an accounting estimate to be made based on assumptions about matters that
are highly uncertain at the time the estimate is made, and if different estimates that reasonably could have been used, or changes in
the accounting estimate that are reasonably likely to occur, could materially impact the consolidated financial statements. We believe
that the following critical accounting policies reflect the more significant estimates and assumptions used in the preparation of the
consolidated financial statements.
Income
Taxes
The
Company follows the asset and liability method of accounting for future income taxes. Under this method, future income tax assets and
liabilities are recorded based on temporary differences between the carrying amount of assets and liabilities and their corresponding
tax basis. In addition, the future benefits of income tax assets including unused tax losses, are recognized, subject to a valuation
allowance to the extent that it is more likely than not that such future benefits will ultimately be realized. Future income tax assets
and liabilities are measured using enacted tax rates and laws expected to apply when the tax liabilities or assets are to be either settled
or realized. The Company’s effective tax rate approximates the Federal statutory rates.
11
Results
of Operations for the Year Ended December 31, 2021 compared to the Year Ended December 31, 2020
In
the summer of 2014, the Company decided to discontinue all operations. After the change of control on November 3, 2020, the Company’s
operations are determined and structured by the new major shareholder.
During
the years ended December 31, 2021 and 2020, we generated no revenues.
Operating
expenses, including general and administrative expenses, during the year ended December 31, 2021, was $46,276 compared to $18,909 during
the year ended December 31, 2020, an increase of $27,367 or 145%. The increase was mainly due to the higher professional fees related
to the change of control and the filing of form 10 to become a SEC reporting company
During
the year ended December 31, 2021, the Company incurred a net loss of $46,276, compared to a net loss of $17,642 during the year ended
December 31, 2020. The $28,634 increase in net loss was primarily due to the increase in operating expenses.
Liquidity
and Capital Resources
As
of December 31, 2021, and 2020, we had a cash balance of $0. Due to the lack of revenue, the company’s operations are primarily
funded by the Company’s CEO and major shareholder.
To
the extent that the Company’s capital resources are insufficient to meet current or planned operating requirements, the Company
will seek additional funds through equity or debt financing, collaborative or other arrangements with corporate partners, licensees or
others, and from other sources, which may have the effect of diluting the holdings of existing shareholders. The Company has no current
arrangements with respect to, or sources of, such additional financing and the Company does not anticipate that existing shareholders
will provide any portion of the Company’s future financing requirements. Ms. Xudong, the CEO and principal shareholder of the Company,
would favorably entertain funding, through loans, corporate expenses for approximately 24 months. Any loans by Ms. Xudong would be on
an interest-free basis, documented by a promissory note and payable only upon consummation of a business combination transaction. Upon
consummation of a business combination, we or the target may reimburse Ms. Xudong for any such loans from funds furnished by the target.
We have no written agreement with Ms. Xudong to advance any further funds for future operating expense, therefore there is no assurance
that such funds from Ms. Xudong will be forth coming, if required.
No
assurance can be given that additional financing will be available when needed or that such financing will be available on terms acceptable
to the Company. If adequate funds are not available, the Company may be required to delay or terminate expenditures for certain of its
programs that it would otherwise seek to develop and commercialize. This would have a material adverse effect on the Company. These factors
raise substantial doubt about the ability of the Company to continue as a going concern.
Operating
Activities
Net
cash used in operating activities was $0 during the year ended December 31, 2021 and 2020.
Investing
Activities
We
neither generated nor used cash in investing activities during the year ended December 31, 2021 and 2020.
Financing
Activities
We
neither generated nor used cash in financing activities during the year ended December 31, 2021 and 2020.
Going
Concern
The
accompanying financial statements have been prepared assuming that the Company will continue as a going concern. As shown in the accompanying
financial statements, we have incurred net losses of $46,276 and $17,642 for the year ended December 31, 2021 and 2020, respectively,
and have a working capital deficit of $53,176 as of December 31, 2021, in addition to a stockholder deficit of $53,176, which raise substantial
doubt about the Company’s ability to continue as a going concern.
12
Management
believes the Company will continue to incur losses and negative cash flows from operating activities for the foreseeable future and will
need additional equity or debt financing to sustain its operations until it can achieve profitability and positive cash flows, if ever.
Management plans to seek additional debt and/or equity financing for the Company but cannot assure that such financing will be available
on acceptable terms.
The
Company’s continuation as a going concern is dependent upon its ability to ultimately attain profitable operations, generate sufficient
cash flow to meet its obligations, and obtain additional financing as may be required. Our auditors have included a “going concern”
qualification in their Report of Independent Certified Public Accountants accompanying our audited financial statements appearing elsewhere
herein which cites substantial doubt about our ability to continue as a going concern. Such a “going concern” qualification
may make it more difficult for us to raise funds when needed. The outcome of this uncertainty cannot be assured.
The
accompanying financial statements do not include any adjustments that might result from the outcome of this uncertainty. There can be
no assurance that management will be successful in implementing its business plan or that the successful implementation of such business
plan will actually improve our operating results.
Off
Balance Sheet Arrangements
We
have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our
financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or
capital resources and would be considered material to investors
Inflation
We
do not believe that inflation has had in the past or will have in the future any significant negative impact on our operations.
Item
7A
Quantitative And Qualitative Disclosures About Market
Risk.
This
item does not apply to smaller reporting companies.
Item
8
Financial Statements And Supplementary Data.
Our
financial statements appear beginning on page F-1, immediately following the signature page of this report.
Item
9
Changes In And Disagreements With Accountants On Accounting
And Financial Disclosure.
On
January 29, 2021, we appointed B F Borgers, CPA PC as our new independent auditors.
There
has never been any disagreement with any independent registered public accounting firm that has worked for the Company regarding accounting
and financial disclosure.
Item
9A
Controls And Procedures.
Disclosure
Controls and Procedures
Based
upon an evaluation of the effectiveness of our disclosure controls and procedures performed by our Chief Executive Officer as of the
end of the period covered by this report, our Chief Executive Officer concluded that our disclosure controls and procedures have not
been effective as a result of a weakness in the design of internal control over financial reporting identified below.
13
As
used herein, “disclosure controls and procedures” mean controls and other procedures of our company that are designed to
ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls
and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us
in the reports that we file or submit under the Securities Exchange Act is accumulated and communicated to our management, including
our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions
regarding required disclosure.
Management’s
Annual Report on Internal Control over Financial Reporting
Management
is responsible for establishing and maintaining adequate internal control over financial reporting (“ICFR”), as such term
is defined in Exchange Act Rule 13a-15(f) under the Securities Exchange Act of 1934. Our Chief Executive Officer/Chief Accounting Officer
conducted an evaluation of the effectiveness of our ICFR based on the framework in Internal Control-Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission (“COSO 2013”). Based on management’s evaluation under
the framework, management has concluded that our ICFR was not effective as of December 31, 2021.
We
identified material weaknesses in our ICFR primarily attributable to (i) lack of segregation of incompatible duties; and (ii) insufficient
Board of Directors representation. These weaknesses are due to our inadequate staffing during the period covered by this report and our
lack of working capital to hire additional staff. Management has retained an outside, independent financial consultant to record and
review all financial data, as well as prepare our financial reports, in order to mitigate this weakness. Although management will periodically
re-evaluate this situation, at this point it considers that the risk associated with such lack of segregation of duties and the potential
benefits of adding employees to segregate such duties are not cost justified. We intend to hire additional accounting personnel to assist
with financial reporting as soon as our finances will allow.
This
annual report does not include an attestation report of our registered public accounting firm regarding ICFR. Management’s report
was not subject to attestation by our registered public accounting firm pursuant to temporary rules of the Securities and Exchange Commission
that permit us to provide only management’s report in this annual report.
Item 9B.
Other
Information
Not
applicable
PART
III
Item 10
Directors And Executive Officers And Corporate Governance.
The
following table sets forth the names and ages of all directors and executive officers as of the end of the last fiscal year and on the
date of this report:
Name
Age
Position
Since
Xudong Li
57
President, CFO, Secretary and Director
Nov. 3, 2020
Zhang Haosong
42
Director
Nov. 3, 2020
Xudong
Li, has served as a director, President and Chief Executive Officer of the Company since November 2020. Ms. Xudong is a highly active
business consultant in China. From 2017 to 2019, he served as the General Consultant at Sichuan Commodities Exchange. He also served
as the consultant at Tianjin Commodities Exchange the same period of time. From 2014 to 2016, he served as the General Consultant at
Shaanxi Jeer Health Industry Group. The company, located in Shaanxi, Ankang City, also known as Chinese Selenium Valley, focused on the
R&D, production and sales from Selenium.
14
Zhang
Haosong, Zhang Haosong has been a director of the Company since November 2020. He previously worked at China Life Insurance, as a
special assistant to the chairman and general manager of one of its large company group. He has over 6 years of domestic and foreign
listing counseling experience. He also has expertise in corporate management consulting, equity investments and financing, VIE structure
processing, listed company acquisitions, mergers and acquisitions and restructuring. Over the past five years he has served as a consultant
for many private and listed companies, and Sino-foreign joint ventures. Mr. Zhang attended the France Brest Business School where he
received an MBA.
Each
of our director’s primary qualification to serve as such involves his or her extensive experience with different aspects of counseling
and reviewing opportunities for acquiring businesses for their clients.
Audit
Committee
The
Company does not presently have an Audit Committee and the entire Board acts in such capacity for the immediate future due to the limited
size of the Board. The Company intends to increase the size of its Board in the future, at which time it may appoint an Audit Committee.
In
lieu of an Audit Committee the Board is empowered to make such examinations as are necessary to monitor the corporate financial reporting
and the external audits of The Company, to provide to the Board of Directors (the “Board”) the results of its examinations
and recommendations derived there from, to outline to the Board improvements made, or to be made, in internal control, to nominate independent
auditors, and to provide to the Board such additional information and materials as it may deem necessary to make the Board aware of significant
financial matters that require Board attention.
Compensation
Committee
The
Company does not presently have a Nominating Committee and the Board acts in such capacity for the immediate future due to the limited
size of the Board. The Company intends to increase the size of its Board in the future, at which time it may appoint a Compensation Committee.
The
Compensation Committee will be authorized to review and make recommendations to the Board regarding all forms of compensation to be provided
to the executive officers and directors of The Company, including stock compensation, and bonus compensation to all employees.
Nominating
Committee
The
Company does not have a Nominating Committee and the Board acts in such capacity.
Code
of Conduct and Ethics
To
date, we have not adopted a Code of Ethics applicable to our principal executive officer and principal financial officer because the
Company has no meaningful operations. The Company does not believe that a formal written code of ethics is necessary at this time. We
expect that the Company will adopt a code of ethics if and when the Company successfully completes a business combination that results
in the acquisition of an on-going business and thereby commences operations.
15
Item
11
Executive Compensation.
The
following tables set forth certain information about compensation paid, earned or accrued for services by the Company’s Chief Executive
Officer in the years ended December 31, 2021 and 2020:
Summary
Compensation Table
Name and Principal Position
Year
Salary ($)
Bonus ($)
Stock Awards ($)
Option Awards ($)
Non-Equity Incentive Plan Compensation ($)
Change in Pensions Value and Nonqualified Deferred Compensation Earnings ($)
All Other Compensation ($)
Total ($)
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
(j)
Li Xudong
2021
-
-
-
-
-
-
-
-
CEO (1)
2020
-
-
-
-
-
-
-
-
David Lazar
2020
-
-
-
-
-
-
-
-
CEO (2)
(1)
On November 3, 2020 Ms. Xudong was appointed as CEO, CFO and Secretary.
(2)
On November 3, 2020, Mr. Lazar resigned as CEO, CFO and Secretary.
Employment
Agreement
We
do not have any employment agreements with our officers.
Director’s
Compensation
At
present we do not pay our directors for attending meetings of our Board of Directors.
Item
12.
Security Ownership of Certain Beneficial Owners and
Management and Related Stockholder Matters.
The
following table sets forth as of December 31, 2021 the number and percentage of the outstanding shares of common stock, which, according
to the information available to us, were beneficially owned by:
(i)
each
person who is currently a director,
(ii)
each
executive officer,
(iii)
all
current directors and executive officers as a group, and
(iv)
each
person who is known by us to own beneficially more than 5% of our outstanding common stock.
Except
as otherwise indicated, the persons named in the table have sole voting and dispositive power with respect to all shares beneficially
owned, subject to community property laws where applicable.
Name and Address of Beneficial Owner (1)
Number of Common Shares
Percent of Class
Xudong Li, President, CFO, Secretary and Director
50,000,000
67.0 %
Zhang Haosong, Director
-0-
-0-
All executive officers, beneficial owners, and directors as a group (2)
50,000,000
67.0 %
(1)
c/o
Room 2707, Global Mansion, Zhengbian Road, Jishui District, Zhengzhou City, Henan Provence 450000 China
The
following table sets forth information as of the date of this report regarding the beneficial ownership of the Company’s Series
A-1 Preferred Stock by each of its executive officers and directors, individually and as a group and by each person who beneficially
owns in excess of five percent of the class of stock after giving effect to any exercise of warrants or options held by that person.
16
Name and Position
Shares
Owned
Percent
of
Class (1)
Voting
Percentage (3)
Xudong Li, President, Chief Executive Officer, Director (2)
5,000,000
100 %
91 %
Zhang Haosong, Director
-
-
-
All Officers and directors as a Group (2 persons)
5,000,000
100 %
91 %
(1)
Based
on 5,000,000 shares of Series A-1 Preferred Stock (“Preferred Stock”) outstanding, which, voting together as a class,
have the right to vote 100 shares for each share of Preferred Stock owned of the Company’s voting shares on any and all shareholder
matters (the “Majority Voting Rights”). Additionally, as long as at least an aggregate of 1,000,000 shares of Preferred
Stock are outstanding, the Company shall not, without the approval of the holders of at least a majority of the then outstanding
shares of Preferred Stock, alter or change the provisions of the Certificate of Incorporation so as to adversely affect the voting
powers, preferences or special rights of the Preferred Stock. However, the Company may, by any means authorized by law and without
any vote of the holders of shares of Series A Preferred Stock, make technical, corrective, administrative or similar changes to such
Certificate of Designations that do not, individually or in the aggregate, adversely affect the rights or preferences of the holders
of shares of Preferred Stock. Other than the Majority Voting Rights.
(2)
The
address of the officers and director of the Company is set forth above under the first table of this section
(3)
Based
on aggregate voting shares, including Common Stock shares and Series A-1 Preferred Stock shares, presently issued and outstanding.
Item
13
Certain
Relationships And Related Transactions, And Director Independence.
On
October 04, 2019, the Company issued 50,000,000 shares of common stock to Custodian Ventures, LLC at par for shares valued at $50,000
in exchange for settlement of a portion of a related party loan for amounts advanced to the Company in the amount of $20,100, and a note
receivable due to the Company in the amount of $29,900. The note bears an interest of 3% and matures in 180 days following written demand
by the holder. At December 31, 2020, the note receivable with a balance of $31,383 was written off because the collectability of the
note is unlikely after the change of control, the written off balance of the note consisted of the principal in the amount of $29,900
and interest receivable of $1,483.
On
May 4, 2020, the Company issued 5,000,00 shares of the Series A-1 Preferred stock valued at $5,000 to Custodian Ventures LLC as repayment
of funds loaned to the Company.
During
the year ended December 31, 2021, the Company’s current majority shareholder advanced $46,876 to the Company as working capital.
As of December 31, 2021 and 2020, the Company owed its current majority shareholders of $53,176, and $6,300, respectively. The advances
are non-interest bearing and are due on demand.
Director
Independence
The
Board currently consists of two members, of which Zhang Haosong meets the independence requirements of the Nasdaq Stock Market as currently
in effect.
Item
14
Principal
Accountant Fees And Services.
The
following is a summary of the fees billed to us for professional services rendered by our registered independent public accountants for
the fiscal years ended December 31, 2021 and December 31, 2020:
Fiscal year ended December 31,
2021
2020
Audit Fees
$ 15,500
$ 5,000
Audit Related Fees
-
-
Tax Fees
-
-
All Other Fees
-
-
$ 15,500
$ 5,000
17
Audit
Fees. Consists of fees billed for professional services rendered for the audit of our financial statements and review of interim financial
statements included in quarterly reports and services that are normally provided in connection with statutory and regulatory filings
or engagements.
Audit
Related Fees. Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit
or review of our financial statements and are not reported under “Audit Fees”.
Tax
Fees. Consists of fees billed for professional services for tax compliance, tax advice and tax planning. These services include preparation
of federal and state income tax returns.
All
Other Fees. Consists of fees for product and services other than the services reported above.
Board
of Directors’ Pre-Approval Policies
We
do not have a standing audit committee currently serving and as a result our BOD performs the duties of an audit committee. Our BOD evaluates
and approves, in advance, the scope and cost of the engagement of an accounting firm before the accounting firm renders audit and non-audit
services. We do not rely on pre-approval policies and procedures.
PART
IV
ITEM
15
EXHIBITS
AND FINANCIAL STATEMENT SCHEDULES.
(a)
The
following documents have been filed as a part of this Annual Report on Form 10-K.
1.
Financial
Statements
Years
Ended December 31, 2021 and 2020
Page
Report
of Independent Registered Public Accounting Firm (PCAOB ID: 5041 )
F-1
Balance Sheets as of December 31, 2021 and 2020
F-2
Statements of Operations for the Years Ended December 31, 2021 and 2020
F-3
Statements of Shareholders’ Deficit for the Years Ended December 31, 2021 and 2020
F-4
Statements of Cash Flows for the Years Ended December 31, 2021 and 2020
F-5
Notes to Financial Statements
F-6
2.
Financial
Statement Schedules.
All
schedules are omitted because they are not applicable or not required or because the required information is included in the Financial
Statements or the Notes thereto.
18
3.
Exhibits.
The following exhibits are filed as part of, or incorporated by reference into, this Annual Report:
Exhibit
No.
Description
3.1*
Articles of Incorporation and Amendment thereto.
3.2*
Bylaws
10.1*
Securities Purchase Agreement between Custodian ventures, LLC and Xudong Li dated October 22, 2020
23.1
Consent of Independent Registered Public Accounting Firm
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14 or Rule 15d-14 of Securities Exchange Act of 1934.
32.1
Certification of Chief Executive Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350).
101.INS
Inline XBRL
Instance Document
101.SCH
Inline XBRL
Taxonomy Extension Schema
101.CAL
Inline XBRL
Taxonomy Extension Calculation
101.DEF
Inline XBRL
Taxonomy Extension Definition
101.LAB
Inline XBRL
Taxonomy Extension Label
101.PRE
Inline XBRL
Taxonomy Extension Presentation
104
Cover Page Interactive Data File (embedded within the Inline XBRL document)
*
Previously
filed
19
SIGNATURES
Pursuant
to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.
Date:
March 28, 2022
By:
/s/
Li Xudong
Li
Xudong
Chief
Executive Officer
(Principal
Executive Officer
In
accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities
indicated on March 28, 2022.
Signature
Title
/s/
Li Xudong
Chief
Executive Officer and a Director
Li
Xudong
(Principal
Executive Officer)
/s/
Zhang Haosong
Director
Zhang
Haosong
20
Report
of Independent Registered Public Accounting Firm
To the shareholders and the board of directors of
Hong Yuan Holding Group
Opinion on the Financial Statements
We have audited the accompanying consolidated balance
sheets of Hong Yuan Holding Group as of December 31, 2021 and 2020, the related statements of operations, stockholders’ equity (deficit),
and cash flows for the years then ended, and the related notes (collectively referred to as the “financial statements”). In
our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31,
2021 and 2020, and the results of its operations and its cash flows for the years then ended, in conformity with accounting principles
generally accepted in the United States.
Substantial Doubt about the Company’s Ability
to Continue as a Going Concern
The accompanying financial statements have been prepared
assuming that the Company will continue as a going concern. As discussed in Note 3 to the financial statements, the Company’s significant
operating losses raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any
adjustments that might result from the outcome of this uncertainty.
Basis for Opinion
These financial statements are the responsibility
of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”)
and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable
rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform,
an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal
control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal
control over financial reporting. Accordingly, we express no such opinion.
Our audit included performing procedures to assess
the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond
to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements.
Our audit also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating
the overall presentation of the financial statements. We believe that our audit provides a reasonable basis for our opinion.
Critical Audit Matter
Critical audit matters are
matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the
audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially
challenging, subjective, or complex judgments.
We determined that there
are no critical audit matters.
/S/
BF Borgers CPA PC
We
have served as the Company’s auditor since 2021
Lakewood,
CO
March
28, 2022
F- 1
HONG
YUAN HOLDING GROUP
BALANCE
SHEETS
December 31,
December 31,
2021
2020
ASSETS
Current assets
TOTAL ASSETS
$ -
$ -
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts payable and accrued liabilities
$ -
$ 600
Due to related parties
53,176
6,300
Total Current Liabilities
53,176
6,900
TOTAL LIABILITIES
53,176
6,900
Stockholders’ Deficit
Preferred Stock: 5,000,000 shares authorized; $ 0.001 par value 5,000,000 issued and
outstanding at December 31, 2021 and 2020
5,000
5,000
Common stock: 250,000,000 shares authorized; $ 0.001 par value 74,640,766 shares
issued and outstanding at December 31, 2021 and 2020
74,641
74,641
Paid-in capital
97,186,036
97,186,036
Accumulated deficit during development stage
( 97,318,853 )
( 97,272,577 )
Total Stockholders’ Deficit
( 53,176 )
( 6,900 )
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT
$ -
$ -
The
accompanying notes are an integral part of these consolidated financial statements.
F- 2
HONG
YUAN HOLDING GROUP
STATEMENTS
OF OPERATIONS
2021
2020
Year Ended
December 31,
2021
2020
Operating Expenses
General and administrative
$ 5,255
$ 7,006
Professional fees
41,021
11,903
Total Operating Expenses
46,276
18,909
Operating loss
( 46,276 )
( 18,909 )
Other Income and Expense
Interest income
-
1,267
Total other income (expense)
-
1,267
Provision for income taxes
-
-
Net loss
$ ( 46,276 )
$ ( 17,642 )
Basic and dilutive net loss per common share
$ ( 0.00 )
$ ( 0.00 )
Weighted average number of common shares outstanding - basic and diluted
74,640,970
74,641,132
The
accompanying notes are an integral part of these consolidated financial statements.
F- 3
HONG
YUAN HOLDING GROUP
STATEMENTS
OF STOCKHOLDERS’ EQUITY
Common
Stock:
Shares
Common
Stock:
Amount
Preferred
Stock:
(A-1)
Shares
Preferred
Stock:
Amount
Additional
Paid-in
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income
Totals
Balance – December 31. 2020
74,641,276
$ 74,641
5,000,000
$ 5,000
$ 97,186,036
$ ( 97,272,577 )
$ -
$ ( 6,900 )
Cancellation of common stock
( 510 )
Net loss
-
-
-
-
-
( 46,276 )
-
( 46,276 )
Balance – December 31, 2021
74,640,766
$ 74,641
5,000,000
$ 5,000
$ 97,186,036
$ ( 97,318,835 )
$ -
$ ( 53,176 )
Common
Stock:
Shares
Common
Stock:
Amount
Preferred
Stock:
(A-1)
Shares
Preferred
Stock:
Amount
Additional
Paid-in
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income
Totals
Balance – December 31, 2019
74,640,766
$ 74,641
510
$ -
$ 97,206,117
$ ( 97,254,935 )
$ -
$ 25,823
Beginning balance
74,640,766
$ 74,641
510
$ -
$ 97,206,117
$ ( 97,254,935 )
$ -
$ 25,823
Conversion of preferred stock into common stock
510
-
( 510 )
-
-
-
-
-
Issuance of preferred stock to related party
-
-
5,000,000
5,000
-
-
-
5,000
Due to related party written off upon change of control
-
-
-
-
11,301
-
-
11,301
Notes receivable from related party written off upon change of control
-
-
-
-
( 31,382 )
-
-
( 31,382 )
Net loss
-
-
-
-
-
( 17,642 )
-
( 17,642 )
Balance – December 31, 2020
74,641,276
$ 74,641
5,000,000
$ 5,000
$ 97,186,036
$ ( 97,272,577 )
$ -
$ ( 6,900 )
Ending balance
74,641,276
$ 74,641
5,000,000
$ 5,000
$ 97,186,036
$ ( 97,272,577 )
$ -
$ ( 6,900 )
The
accompanying notes are an integral part of these consolidated financial statements.
F- 4
HONG
YUAN HOLDING GROUP
STATEMENTS
OF CASH FLOWS
Year Ended
December 31,
2021
2020
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss
$ ( 46,276 )
$ ( 17,642 )
Adjustments to reconcile net loss to net cash used in operating activities:
Interest income
-
( 1,266 )
Changes in operating assets and liabilities:
Accounts payable and accrued liabilities
( 600 )
600
Loan payable - related party
46,876
18,308
Net Cash Used in Operating Activities
-
-
CASH FLOWS FROM INVESTING ACTIVITIES
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
-
-
Net change in cash and cash equivalents for the year
-
-
Cash and cash equivalents at beginning of the year
-
-
Cash and cash equivalents at end of the year
$ -
$ -
SUPPLEMENTAL CASH FLOW INFORMATION:
Cash paid for income taxes
$ -
$ -
Cash paid for interest
$ -
$ -
NON-CASH INVESTING AND FINANCING ACTIVITIES
Written off notes receivable, related party
$ -
$ 30,116
Written off due to related party
$ -
$ 11,301
Due to related party converted to preferred stock
$ -
$ 5,000
The
accompanying notes are an integral part of these consolidated financial statements.
F- 5
HONG
YUAN HOLDING GROUP
NOTES
TO FINANCIAL STATEMENTS
Note
1 – Organization and basis of accounting
Basis
of Presentation and Organization
This
summary of significant accounting policies of Hong Yuan Holding Group. (a development stage company) (“the Company”) is presented
to assist in understanding the Company’s financial statements. These accounting policies conform to accounting principles generally
accepted in the United States of America and have been consistently applied in the preparation of the accompanying financial statements.
The Company has realized minimal revenues from its planned principal business purpose and, accordingly, is considered to be in its development
stage in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”)
Topic No. 915 (SFAS No. 7). The Company has elected a fiscal year end of December 31.
Business
Description
We
were incorporated on September 29, 2001 in the State of Nevada under the name of Biocorp North America Inc. On March 18, 2005, we filed
an amendment to our certificate of incorporation to change our name to Cereplast, Inc. We developed and tried to commercialize proprietary
bio-based resins through two complementary product families: Cereplast Compostables ® resins which are compostable, renewable,
ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables™ resins (including the Cereplast Hybrid
Resins product line), which replaces up to 90 % of the petroleum-based content of traditional plastics with materials from renewable resources.
On
February 10, 2014, the Company, filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Bankruptcy Code
in the United States Bankruptcy Court for the Southern District of Indiana (the “Bankruptcy Court “). On February 14, 2014,
the Company filed a motion in the Bankruptcy Court seeking to convert the Company’s Chapter 11 Case to a Chapter 7 bankruptcy case.
On March 27, 2014, the court granted the Company’s motion and on that date the Company’s Chapter 11 Case was converted to
a Chapter 7 case. As a result, the Company adopted liquidation basis of accounting on the discontinued operations according to ASC 205-30
“Presentation of Financial Statements – Liquidation Basis of Accounting”, accordingly the accumulated deficit generated
prior to bankruptcy proceedings remained unadjusted.
On
January 31, 2014 the Board of Directors of Cereplast, Inc. (the “Company”) approved a 1-for-50 reverse split (the “Reverse
Split) which was previously approved by the shareholders on April 5, 2013 and previously disclosed on Current Report Form 8-K filed on
April 5, 2013 .
On
February 3, 2014, Cereplast, Inc. (the “Company”) filed a Certificate of Amendment to its Articles of Incorporation to effect
the reverse split (the “Reverse Split”), effective as of February 21, 2014.
On
March 22, 2019, the eight judicial District Court of Nevada appointed Custodian Ventures, LLC as custodian for Cereplast, Inc., proper
notice having been given to the officers and directors of Cereplast, Inc. There was no opposition.
On
June 04, 2019, the Company filed a certificate of revival with the state of Nevada, appointing David Lazar as, President, Secretary,
Treasurer and Director.
On
October 4, 2019, the Company issued 50,000,000 shares of common stock to Custodian Ventures, LLC at par for shares valued at $ 50,000
in exchange for settlement of a portion of a related party loan for amounts advanced to the Company in the amount of $ 20,100 , and a note
receivable due to the Company in the amount of $ 29,900 . The note bears an interest of 3 % and matures in 180 days following written demand
by the holder.
On
April 14, 2020, Custodian Ventures elected to convert the total amount of the 510 shares of Series A preferred stock into 510 shares
of common stock.
F- 6
On
April 15, 2020, the Board of directors of the Company approved the withdrawal of the certificate of designation of 5,000,000 shares of
Series A Preferred stock filed with the Nevada Secretary of State on August 24, 2012, as amended by the Amendment to Certificate of Designation
after issuance of Class or Series filed with the Nevada Secretary of State on April 13, 2020.
On
May 1, 2020, the Company created 5,000,000 shares of series A-1 preferred stock with par value $ 0.001 . On May 4, 2020, the Company issued
5,000,00 shares of the Series A-1 Preferred stock valued at $ 5,000 to Custodian Ventures LLC as repayment funds loaned to the Company.
A
change of control of the Company was completed on November 3, 2020, control was obtained by the sale of 50,000,000 common shares and
$ 5,000,000 Series A-1 Preferred Shares from Custodian Ventures, LLC to Xudong Li. After November 3, 2020, the Company’s operations
are determined and structured by the new major shareholder.
On
November 18, 2020, the Company filed an amendment to its certificate of incorporation to change its name to Hong Yuan Holding Group.
The
accompanying financial statements are prepared on the basis of accounting principles generally accepted in the United States of America
(“GAAP”). The Company is a development stage enterprise devoting substantial efforts to establishing a new business, financial
planning, raising capital, and research into products which may become part of the Company’s product portfolio. The Company has
not realized significant sales since inception. A development stage company is defined as one in which all efforts are devoted substantially
to establishing a new business and, even if planned principal operations have commenced, revenues are insignificant.
The
accompanying financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has not
yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to
fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating
to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation
and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital, or be successful
in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying
financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of
assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going
concern.
Note
2 – Summary of significant accounting policies
Cash
and Cash Equivalents
For
purposes of reporting within the statements of cash flows, the Company considers all cash on hand, cash accounts not subject to withdrawal
restrictions or penalties, and all highly liquid debt instruments purchased with a maturity of three months or less to be cash and cash
equivalents.
Employee
Stock-Based Compensation
The
Company accounts for stock-based compensation in accordance with ASC 718 Compensation - Stock Compensation (“ASC 718”). ASC
718 addresses all forms of share-based payment (“SBP”) awards including shares issued under employee stock purchase plans
and stock incentive shares. Under ASC 718 awards result in a cost that is measured at fair value on the awards’ grant date, based
on the estimated number of awards that are expected to vest and will result in a charge to operations.
Loss
per Share
Basic
earnings (loss) per share are computed by dividing income available to common shareholders by the weighted-average number of common shares
available. Diluted earnings (loss) per share is computed similar to basic earnings per share except that the denominator is increased
to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and
if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for
the years ended December 31, 2021 and 2020, as there are no potential shares outstanding that would have a dilutive effect.
F- 7
Income
Taxes
Income
tax expense is based on pretax financial accounting income. Deferred tax assets and liabilities are recognized for the expected tax consequences
of temporary differences between the tax bases of assets and liabilities and their reported amounts. Valuation allowances are recorded
to reduce deferred tax assets to the amount that will more likely than not be realized. The Company recorded a valuation allowance against
its deferred tax assets as of December 31, 2021 and 2020.
The
Company accounts for uncertainty in income taxes using a two-step approach to recognizing and measuring uncertain tax positions. The
first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more
likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any.
The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. The
Company classifies the liability for unrecognized tax benefits as current to the extent that the Company anticipates payment (or receipt)
of cash within one year. Interest and penalties related to uncertain tax positions are recognized in the provision for income taxes.
Recent
Accounting Pronouncements
In
December 2019, the FASB issued ASU No. 2019-12, Simplifying the Accounting for Income Taxes, as part of its initiative to reduce complexity
in accounting standards. The amendments in the ASU are effective for fiscal years beginning after December 15, 2020, including interim
periods therein. Early adoption of the standard is permitted, including adoption in interim or annual periods for which financial statements
have not yet been issued. The Company is currently evaluating the effect, if any, that the ASU will have on its consolidated financial
statements.
Note
3- Going Concern
The
accompanying financial statements have been prepared assuming the continuation of the Company as a going concern. The Company has not
yet established an ongoing source of revenues sufficient to cover its operating costs and is dependent on debt and equity financing to
fund its operations. Management of the Company is making efforts to raise additional funding until a registration statement relating
to an equity funding facility is in effect. While management of the Company believes that it will be successful in its capital formation
and planned operating activities, there can be no assurance that the Company will be able to raise additional equity capital or be successful
in the development and commercialization of the products it develops or initiates collaboration agreements thereon. The accompanying
financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of
assets or the amounts and classification of liabilities that may result from the possible inability of the Company to continue as a going
concern.
Note
4 – Related Party Transaction
On
October 04, 2019, the Company issued 50,000,000 shares of common stock to Custodian Ventures, LLC at par for shares valued at $ 50,000
in exchange for settlement of a portion of a related party loan for amounts advanced to the Company in the amount of $ 20,100 , and a note
receivable due to the Company in the amount of $ 29,900 . The note bears an interest of 3 % and matures in 180 days following written demand
by the holder. At December 31, 2020, the note receivable with a balance of $31,383 was written off because the collectability of the
note is unlikely after the change of control, the written off balance of the note consisted of the principal in the amount of $29,900
and interest receivable of $1,483.
On
May 4, 2020, the Company issued 5,000,00 shares of the Series A-1 Preferred stock valued at $ 5,000 to Custodian Ventures LLC as repayment
of funds loaned to the Company.
F- 8
During
the year ended December 31, 2021, the Company’s current majority shareholder advanced $ 46,876 to the Company as working capital.
As of December 31, 2021 and 2020, the Company owed its current majority shareholders of $ 53,176 , and $ 6,300 , respectively. The advances
are non-interest bearing and are due on demand.
Note
5 – Common Stock
On
October 4, 2019, the Company issued 50,000,000
shares of common stock to Custodian Ventures,
LLC at par for shares valued at $ 50,000
in exchange for settlement of a portion of a
related party loan for amounts advanced to the Company in the amount of $ 20,100 ,
and a note receivable due to the Company in the amount of $ 29,900 .
The note bears an interest of 3 %
and matures in 180
days following written demand by the holder. At
December 31, 2020, the note receivable with a balance of $ 31,383 was written off because the collectability of the note is unlikely after
the change of control.
On
April 14, 2020, Custodian Ventures elected to convert the total amount of the 510 shares of Series A preferred stock into 510 shares
of common stock.
On
May 27, 2021, the 510 shares of common stock issued to Custodian Ventures were cancelled.
As
of December 31, 2021, a total of 74,640,766 shares of common stock with par value $ 0.001 remain outstanding.
Note
6 – Preferred Stock
On
October 4, 2019, the Company issued 510 shares of Series A Preferred stock to Custodian Ventures, LLC at par for shares valued at $ 510
in exchange for settlement of a portion of a related party loan for amounts advanced to the Company in the amount of $ 510 .
On
April 14, 2020, Custodian Ventures elected to convert the total amount of the 510 shares of Series A preferred stock into 510 shares
of common stock.
On
April 15, 2020, the Board of directors of the Company approved the withdrawal of the certificate of designation of 5,000,000 shares of
Series A Preferred stock filed with the Nevada Secretary of State on August 24, 2012, as amended by the Amendment to Certificate of Designation
after issuance of Class or Series filed with the Nevada Secretary of State on April 13, 2020.
On
May 1, 2020, the Company created 5,000,000 shares of series A-1 preferred stock with par value $ 0.001 . On May 4, 2020, the Company issued
5,000,000 shares of the Series A-1 Preferred stock valued at $ 5,000 to Custodian Ventures LLC as repayment funds loaned to the Company .
As
of December 31, 2021, a total of 5,000,000 shares of Series A-1 preferred stock with par value $ 0.001 remain outstanding.
Note
7 – Income
Taxes
Deferred
taxes represent the net tax effects of the temporary differences between the carrying amounts of assets and liabilities for financial
reporting purposes. Temporary differences result primarily from the recording of tax benefits of net operating loss carry forwards.
As
of December 31, 2021, the Company has an insufficient history to support the likelihood of ultimate realization of the benefit associated
with the deferred tax asset. Accordingly, a valuation allowance has been established for the full amount of the net deferred tax asset.
F- 9
The
Company’s effective income tax rate differs from the amount computed by applying the federal statutory income tax rate to loss
before income taxes for the years ended December 31, 2021 and 2020 as follows:
SCHEDULE
OF PRETAX INCOME FROM CONTINUING OPERATIONS
2021
2020
Year Ended December 31,
2021
2020
Income tax benefit at federal statutory rate
21 %
21 %
Change in valuation allowance
- 21 %
- 21 %
Income tax expenses benefit
- %
- %
The
components of deferred taxes consist of the following at December 31, 2021 and 2020:
SCHEDULE
OF DEFERRED TAX ASSETS AND LIABILITIES
December 31,
2021
December 31,
2020
Net operating loss carryforwards
$ 20,436,959
$ 20,427,241
Less: valuation allowance
( 20,436,959 )
( 20,427,241 )
Net deferred tax assets
$ -
$ -
Uncertain
Tax Positions
Interest
associated with unrecognized tax benefits are classified as income tax, and penalties are classified in selling, general and administrative
expenses in the statements of operations. For December 31, 2021 and 2020, the Company had no unrecognized tax benefits and related interest
and penalties expenses. Currently, the Company is not subject to examination by major tax jurisdictions.
Note
8 – Subsequent Event
In
accordance with SFAS 165 (ASC 855-10) management has performed an evaluation of subsequent events through the date that the financial
statements were available to be issued, and has determined that it does not have any material subsequent events to disclose in these
financial statements.
F- 10
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.